Unlock stock picks and a broker-level newsfeed that powers Wall Street.

KSE - Delayed Quote KRW

Kukje Pharma Co., Ltd. (002720.KS)

Compare
4,710.00
+35.00
+(0.75%)
At close: 3:30:18 PM GMT+9

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in KRW.
NameTitlePayExercisedYear Born
Tae-hoon Nam Chief Executive Officer -- -- --

Kukje Pharma Co., Ltd.

96-8, Yatap-ro
Bundang-gu
Seongnam-si
South Korea
82 3 1781 9081 https://www.kukjepharm.co.kr
Sector: 
Healthcare

Description

Kukje Pharma Co., Ltd. engages in manufacturing, importing, exporting, selling, and distributing pharmaceutical products. The company offers pharmaceutical products, including ETC and OTC products, raw materials, intermediates, and side chain products, as well as cosmetics and health care products. Its products include cephalosporins, quinolones, tetracycline, aminoglycosides, macrolides, other antibiotics, ophthalmic, antifungal and antiviral agents, ophthalmic agents, adrenal corticosteroids, CNS and osteoporotic agents, antihistamines, NSAIDS and other analgesics, gastrointestinal and cardiovascular agents, antidiabetics, genitourinary and respiratory agents, other ETC products, and other products. Kukje Pharma Co., Ltd. was founded in 1959 and is headquartered in Seongnam-si, South Korea.

Corporate Governance

Kukje Pharma Co., Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

March 13, 2025 at 12:00 AM UTC

Ex-Dividend Date